Skip to content

GS-9350 boosts atazanavir just as well as ritonavir

Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs

Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression

Boosted protease inhibitor regimens with 3TC work despite M184V resistance

Maturation inhibitor bevirimat is well tolerated and effective in predicted responders

GSK's second integrase inhibitor looks potent and well-tolerated in early study

Nutritional formula linked to reduced CD4 cell loss in untreated people

IL-7 may boost CD4 and CD8 T-cells, study shows

TB treatment guidelines need to change, systematic reviews show